Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

3SBio’s Shareholders Approve Go-Private Transaction

publication date: May 24, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
3SBio Inc. will go private. A full 87% of company's shareholders voted in favor of the $16.70 per ADS amended offer. The apparent unanimity is far different that the situation one month ago. At that time, the acquiring group was forced to raise the price of the offer from $15.40 per ADS to $16.70. Some of the company’s major shareholders threatened to vote against the transaction because prospective bidders, who proposed offering up to $20, were pressured out of the process. More details....

Stock Symbol: (NSDQ: SSRX)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...